Roche announces collaboration with Atea Pharmaceuticals to develop a potential oral treatment for COVID-19 patients Published on October 22, 2020 COVID-19/Health and Beauty 1082 views Roche and Atea partner to jointly develop AT-527, an orally administered direct-acting antiviral (DAA) currently in Phase 2 clinical trials More